InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,308.80
(
0.06%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
73.60
(
-0.39%
)
Bitcoin
63,333.36
(
-0.45%
)
Post# of 29598
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 14
Posts 3835
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: DewDiligence post# 18722

Thursday, 05/16/2019 12:38:53 PM

Thursday, May 16, 2019 12:38:53 PM

Post# of 29598
They skip the sham-TTF in trials. Excuses were the extra burden to both patients and caregivers. I don't know enough about the history of the device other than the original PMA was granted in 2011. There must have been data backing the efficacy of TTF. Insurance carriers will ask for sham data or trial given ASCO 2019 abstract.

https://www.ncbi.nlm.nih.gov/books/NBK513128/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up